Addition of Sirolimus to Cyclosporine Delays the Recovery from Delayed Graft Function but Does not Affect 1-Year Graft Function

Journal of the American Society of Nephrology

Volumn 15, Issue 1, 2004, Pages 228-233

  Stallone, Giovanni ^a   Di Paolo, Salvatore ^a   Schena, Antonio ^a   Infante, Barbara ^a   Battaglia, Michele ^a   Ditonno, Pasquale ^a   Gesualdo, Loreto ^b   Grandaliano, Giuseppe ^a   Schena, Francesco Paolo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN;

ADULT; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0347364668     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000102469.32182.8C     Document Type: Article

References (29)

1. McLaren AJ, Jassem W, Gray DW, Fuggle SV, Welsh KI, Morris PJ: Delayed graft function: Risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant 13: 266-271, 1999
2. Troppmann C, Gillingham KJ, Gruessner RW, Dunn DL, Payne WD, Najarian JS, Matas AJ: Delayed graft function in the absence of rejection has no long-term impact: A study of cadaveric kidney recipients with good graft function at 1 year after transplantation. Transplantation 61: 1331-1338, 1996
3. Nicholson ML, Wheatley TJ, Horsburgh T, Edwards CM, Veitch PS, Bell PR: The relative influence of delayed graft function and acute rejection on renal transplant survival. Transpl Int 9: 415-421, 1996
4. Shoskes DA, Cecka JM: Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 66: 1697-1704, 1998
5. Giral-Classe M, Hourmant M, Cantarovich D, Dantal J, Blancho G, Daguin P, Ancelet D, Soulillou JP: Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 54: 972-978, 1998
6. Lindholm A, Kahan BD: Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 54: 205-211, 1993
7. Nashan B, Moore R, Amlot P, Schmidt A-G, Abeywickrama K, Soulillou J-P: Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. Lancet 350: 1193-1197, 1997
8. Li XC, Roy-Chaudhury P, Hancock WW, Manfro R, Zand MS, Li Y, Zheng XX, Nickerson PW, Steiger J, Malek TR, Strom TB: IL-2 and IL-4 double knockout mice reject islet allografts: A role for novel T cell growth factors in allograft rejection. J Immunol 161: 890-896, 1998
9. Sehgal SN: Rapamune (RAPA, rapamycin, sirolimus): Mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 31: 335-341, 1998
10. Hong JC, Kahan BD: Two paradigms for new immunosuppressive strategies in organ transplantation. Curr Opin Organ Transplant 3: 175-178, 1998
11. Chung J, Kuo CJ, Crabtree GR, Blenis J: Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70kd s6 protein kinases. Cell 69: 1227-1236, 1992
12. Lieberthal W, Fuhro R, Andry CC, Rennke H, Abernathy VE, Koh JS, Valeri R, Levine JS: Rapamycin impairs recovery from acute renal failure: Role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 281: 693-706, 2001
13. Keller G, Zimmer G, Mall G, Ritz E, Amann K: Nephron number in patients with primary hypertension. New Engl J Med 348: 101-108, 2003
14. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y, et al: The Banff 97 working classification of renal allograft pathology. Kidney Int 55: 713-721, 1999
15. Nankivell BJ, Gruenland SM, Allen RDM, Chapman JR: Predicting glomerular filtration rate after kidney transplantation. Transplantation 59: 1683-1689, 1995
16. Smith KD, Wrenshall LE, Nicosia RF, Pichler R, Marsh CL, Alpers CE, Polissar N, Davis CL: Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol 14: 1037-1045, 2003
17. McTaggart RA, Gottlieb D, Brooks JH, Bacchetti P, Roberts JP, Tomlanovich S, Feng S: Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant 3: 416-423, 2003
18. Johnson RW, Kreis H, Oberbauer R, Brattstrom C, Claesson K, Eris J: Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation 72: 777-782, 2001
19. Baboolal K, Jones GA, Janezic A, Griffiths DR, Jurewicz WA: Molecular and structural consequences of early renal allograft injury. Kidney Int 61: 686-692, 2002
20. Andoh TF, Lindsley J, Franceschini N, Bennett WM: Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model. Transplantation 62: 311-317, 1996
21. Lieberthal W, Koh JS, Levine JS: Necrosis and apoptosis in acute renal failure. Semin Nephrol 18: 505-518, 1998
22. Witzgall R, Brown D, Schwartz C, Bonventre JV: Localization of proliferating cell nuclear antigen, vimentin, c-fos and clustering in postischemic kidney. Evidence for a heterogeneous genetic response among nephron segments and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93: 2175-218, 1994
23. Campistol JM, Sacks SH: Mechanisms of nephrotoxicity. Transplantation 69[Suppl]: SS5-SS10, 2000
24. Cecka JM: The UNOS Scientific Renal Transplant Registry. In: Clinical Transplantation 1998, edited by Cecka JM, Terasaki PI, Los Angeles, UCLA Tissue Typing Laboratory, 1999, pp 1-16
25. Lehtonen SRK. Isoniemi HM, Salmela KT, Taskinen EI, Willebrand EO, Ahonen JP: Long-term graft outcome is not necessarily affected by delayed onset of graft function and early acute rejection. Transplantation 64: 103-110, 1997
26. Prommool S, Jhangri GS, Cockfield SM, Halloran PF: Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol 11: 565-573, 2000
27. Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC: Delayed graft function influences renal function, but not survival. Kidney Int 58: 859-866, 2000
28. Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP, for the Sirolimus Renal Function Study Group: Improved renal function in Sirolimus-treated renal transplant patients after early cyclosporine elimination. Transplantation 74: 1560-1567, 2002
29. Stallone G, Di Paolo S, Schena A, Infante B, Grandaliano G, Battaglia M, Gesualdo L, Schena FP: Early withdrawal of cyclosporine improves 1-year kidney graft structure and function in Sirolimus-treated patients. Transplantation 75: 998-1003, 2003